Received May 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y019318 | — |
No additional AE reported. No PQC reported.; a dose of VARIVAX was administered to one patient after short date of temperature excursion.; This spontaneous report was received from a consumer or other non-health professional (reported as health business professional (HBP) (also reporter as other) and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, previous drugs reactions and allergies were not reported. On 31-Mar-2026, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka-merck) (VARIVAX), injection, administered as prophylaxis (Lot No. Y019318 has been verified to be a valid lot number for [varicella virus vaccine live (oka-merck)], expiration date reported and upon internal validation established as 21-Nov-2026) (strength, dose number, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided); that was reconstituted with sterile diluent (Lot No., expiration date and indication were not provided) (product storage issue). No additional adverse event reported. No PQC reported (No adverse event).
MERCK STERILE DILUENT